0001209191-22-043736.txt : 20220801 0001209191-22-043736.hdr.sgml : 20220801 20220801181902 ACCESSION NUMBER: 0001209191-22-043736 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220728 FILED AS OF DATE: 20220801 DATE AS OF CHANGE: 20220801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VINCENT RICHARD G CENTRAL INDEX KEY: 0001269341 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 221126208 MAIL ADDRESS: STREET 1: C/O WOMEN FIRST HEALTH CARE STREET 2: 5355 MIRA SORRENTO PLACE STE. 700 CITY: SAN DIEGO STATE: CA ZIP: 92121-3825 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-28 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001269341 VINCENT RICHARD G 12230 EL CAMINO REAL, SUITE 230 SAN DIEGO CA 92130 0 1 0 0 Chief Financial Officer Common Stock 2022-07-28 4 A 0 43125 0.00 A 131287 D Common Stock 4526 I By Family Trust Common Stock 1834 I By Child Stock Option 1.04 2022-07-28 4 A 0 28750 0.00 A 2032-07-28 Common Stock 28750 28750 D Represents an award of restricted stock units (RSUs). Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. One half of the RSUs vest on July 3, 2023, and one half of the RSUs vest on January 3, 2024, subject to the Reporting Person's continued employment or service with the Issuer on each such date. All of the RSUs vest in the event of a Change in Control (as defined in the Issuer's 2019 Incentive Award Plan). One half of the shares subject to the stock options vest on July 3, 2023 and one half of the shares subject to the stock options vest on January 3, 2024, subject to the Reporting Person's continued employment or service with the Issuer on each such date. All of the shares subject to the stock options vest in the event of a Change in Control (as defined in the Issuer's 2019 Incentive Award Plan). /s/Chase C. Leavitt, Attorney-in-fact 2022-08-01